Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ovarian Function Inhibition of E4/DRSP vs EE/DRSP
NCT03091595Phase 2Completed
- Sponsor
- Estetra SRL
- Start
- Feb 2017
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of estetrol in contraception (2 arms), sponsored by Estetra SRL. Primary endpoint: Proportion of subjects with ovarian inhibition at Cycle 3. Started Feb 2017; status: completed.
02
Drugs
estetrol
03
Conditions
contraception
Beyond the preview
Go deeper on NCT03091595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03091595.